Introduction {#s1}
============

Leukocyte-endothelial cell interactions and leukocyte activation are important factors for onset and progression of vascular diseases including nephropathy, retinopathy, cardiomyopathy, neuropathy and angiopathy [@pone.0038912-Chow1], [@pone.0038912-Geraldes1], [@pone.0038912-AlShabrawey1], [@pone.0038912-Julius1]. It is reported that the presence of leukocytes along the endothelium and the activation of leukocytes results in complications such as tissue edema and multiple organ failure [@pone.0038912-Sumagin1], [@pone.0038912-He1], [@pone.0038912-He2]. Studies have shown that leukocyte-endothelial cell interactions are necessary for onset of microvascular dysfunction and tissue injury [@pone.0038912-Kubes1], [@pone.0038912-Wang1], [@pone.0038912-Vedder1]. However, anti-adhesion therapies used to prevent vascular complications arising from leukocyte-endothelial cell interactions have not been very successful [@pone.0038912-He2].

Vascular disease conditions increase oxidative stress in endothelial cells, resulting in endothelial dysfunction [@pone.0038912-Hink1]. As shown in [Figure 1](#pone-0038912-g001){ref-type="fig"}, endothelial dysfunction is characterized by increased superoxide (O~2~ ^•−^) production from endothelium and a reduction in NO bioavailability [@pone.0038912-Hink1], [@pone.0038912-Paolocci1]. There are many hypotheses for the reduction in NO bioavailability. The most important characteristic is a rapid reaction between NO and O~2~ ^•−^ to form peroxynitrite, which may reduce the NO availability even when NO production is increased under oxidative stress conditions [@pone.0038912-Wilcox1], [@pone.0038912-Steiner1]. The increased oxidative stress increases cytokines, inflammatory agents and adhesion molecules expression on the endothelial cell surface and their ligands expression on the surface of the leukocytes [@pone.0038912-Sumagin2], [@pone.0038912-Thorlacius1] resulting in recruitment of leukocytes to the endothelium [@pone.0038912-Geraldes1], [@pone.0038912-Sumagin2], [@pone.0038912-Thorlacius1], [@pone.0038912-Sumagin3].

![Schematic representation of the role of endothelial dysfunction on leukocyte related events through interactions between free radical species (NO, ROS and peroxynitrite).\
The free radical species are represented by the orange ovals, the leukocyte related events and endothelial dysfunction are represented by the yellow compartments and the chemical species expressed as a result of the interactions of free radicals (cytokines, adhesion molecules and inflammatory agents) are represented by the light green compartments. Endothelial dysfunction leads to increased ROS production from endothelium and a possible reduction in NO availability (indicated by the dashed lines). The ROS and NO combine to form peroynitrite (Per). ROS and peroxynitrite increase expression of adhesion molecules and cytokines leading to leukocyte recruitment and priming. Peroxynitrite and ROS can also prime and activate primed leukocytes, respectively. The dashed lines connecting the leukocyte related events shows the uncertaintly associated with their sequential nature.](pone.0038912.g001){#pone-0038912-g001}

The process of leukocyte activation and transmigration is complex. Before activation of leukocyte, the leukocytes are converted to semi-activated state by a process of priming with the aid of priming agents [@pone.0038912-He2], [@pone.0038912-Hayashi1]. Priming agents include peroxynitrite [@pone.0038912-Rohn1], cytokines (TNF-α) and pro-inflammatory agents PAF (platelet-activating factor) and leukotriene B~4~ [@pone.0038912-He1], [@pone.0038912-He2], [@pone.0038912-Kubes1]. Secondary stimuli such as reactive oxygen species (ROS) are required to activate primed leukocytes [@pone.0038912-He1], [@pone.0038912-Bellavite1]. Upon activation, leukocytes release nitric oxide (NO), ROS and cytokines [@pone.0038912-He2], [@pone.0038912-Hayashi1], [@pone.0038912-Mastej1]. In literature, there is no clear evidence that leukocyte recruitment, priming and activation are sequential. There are multiple sources of ROS in blood vessel. ROS from endothelium may act as a secondary stimuli and activate primed leukocytes.

It has been reported that excess NO and O~2~ ^•−^ production in the vasculature from leukocyte-endothelial cell interactions causes significant increase in peroxynitrite formation as indicated by increased tyrosine nitration [@pone.0038912-Zheng1]. Therefore, together with NO and O~2~ ^•−^, the formation of peroxynitrite are important contributors for the vascular disorders [@pone.0038912-Julius1], [@pone.0038912-Hayashi1]. The release of NO and O~2~ ^•−^ by leukocytes increases O~2~ ^•−^ and peroxynitrite concentration within different regions of the microvasculature [@pone.0038912-Csanyi1], [@pone.0038912-Granger1] and increases endothelial cell Ca^2+^ levels [@pone.0038912-He1], [@pone.0038912-Zhu1]. The increase in endothelial cell Ca^2+^ levels initiates signaling pathways for increasing vascular permeability [@pone.0038912-Zhu1]. Increased vascular permeability causes extravasation of leukocytes into the tissue region leading to tissue injury and complications such as tissue edema [@pone.0038912-He2], [@pone.0038912-Sarelius1].

Many studies have investigated the effects of leukocyte-endothelial cell interactions on microvascular functions including permeability [@pone.0038912-Sumagin1], [@pone.0038912-Kubes1], [@pone.0038912-Zhu1], vascular tone [@pone.0038912-Bertuglia1],vessel hemodynamics [@pone.0038912-Jariyapongskul1], [@pone.0038912-Kunkel1], tissue injury [@pone.0038912-Vedder1], [@pone.0038912-Gujral1] and organ dysfunction [@pone.0038912-Bertuglia1]. Majority of these studies focused on venular microcirculation. However, there is increasing evidence of leukocyte-endothelial cells interaction in arteriolar microcirculation [@pone.0038912-Sumagin1], [@pone.0038912-Sumagin2], [@pone.0038912-Thorlacius1], [@pone.0038912-Sumagin3], [@pone.0038912-Sarelius1], [@pone.0038912-Kunkel1]. The expression of adhesion molecules is upregulated in arteriolar endothelium under inflammatory conditions [@pone.0038912-Sumagin1], [@pone.0038912-Sumagin2], [@pone.0038912-Thorlacius1], [@pone.0038912-Kunkel1] similar to venules. The leukocyte-endothelial cell interactions between venules and arterioles varies in terms of the adhesion molecules expression levels and their contribution to leukocyte-endothelial interaction and number of leukocytes adhering along the endothelium [@pone.0038912-Sumagin2], [@pone.0038912-Sumagin3]. Besides the changes in vessel parameters and surrounding cells in arterioles and venules, RBCs in venules are relatively unbound to O~2~ whereas RBC are bound to oxygen in arterioles [@pone.0038912-Popel1]. Though a significant number of leukocytes can adhere to the venular endothelium and eventually transmigrate [@pone.0038912-Sumagin3], a small number of leukocytes is reported to interact with the arteriolar endothelium [@pone.0038912-Sumagin2], [@pone.0038912-Sumagin3].

Despite the minimal interactions of leukocyte-endothelial cell in arterioles, the vascular disorders in arteriolar microcirculation are similar to those observed in venules [@pone.0038912-Sumagin1], [@pone.0038912-Sumagin2], [@pone.0038912-Sumagin3]. Okamoto et al. [@pone.0038912-Okamoto1] reported an increased inflammation in the adventitial region of coronary arterioles that is attributed to increased expression of adhesion molecules in the endothelium, leukocyte infiltration into the adventitia and release of ROS by the leukocytes. Murohara et al. [@pone.0038912-Murohara1] reported that H~2~O~2~ (a ROS) treated arteries showed significant increase in vasoconstriction and adhesion of leukocytes to the endothelium. In addition, Suamgin et al. [@pone.0038912-Sumagin1] reported an increase in vessel permeability on transition from control to inflammatory conditions for arterioles and venules. Studies have also shown that increased leukocyte-endothelial cell interactions can lead to increased O~2~ ^•−^ production from the leukocytes [@pone.0038912-Kubes1] and the endothelium [@pone.0038912-Wang1]. The increase in O~2~ ^•−^ production from the leukocytes and endothelium lowers the bioavailability of NO by converting it to peroxynitrite [@pone.0038912-Hayashi1], [@pone.0038912-Zheng1]. These studies suggests the possible role that leukocyte-endothelial cell interaction in the vessel NO and peroxynitrite levels can also contribute to vascular disorders in the arterial side of microcirculation. Thus, it is important to understand the transport and interactions of NO, O~2~ ^•−^ and peroxynitrite in the microcirculation during leukocyte-endothelial cell interaction.

In this study, we examined the biochemical aspects of oxidative stress distribution during the presence of leukocytes (both inactive and activated states) along the endothelium to understand the effects of leukocyte-endothelium interaction on NO, O~2~ ^•−^ and peroxynitrite profiles. A computational model simulating the biotransport of these species in an arteriolar vessel with leukocytes positioned along the luminal surface of the endothelium was developed in both inactive and active state under several endothelial oxidative stress states. Additionally, the effect of the anti-oxidant superoxide dismutase on the arteriolar NO, O~2~ ^•−^ and peroxynitrite concentration distribution was also analyzed.

Materials and Methods {#s2}
=====================

A computational model representing the transport of NO, O~2~ ^•−^ and peroxynitrite in an arteriole of 50 µm diameter and 500 µm length was developed in this study. Three elliptical leukocytes were positioned along the luminal side of the endothelium. We were interested in understanding the effects of the presence of these leukocytes on the local oxidative and nitrosative stress distribution in the vessel. The model simulations predicted the NO, O~2~ ^•−^ and peroxynitrite concentration at different regions of the arteriole and within these leukocytes.

Model Geometry {#s2a}
--------------

A cylindrical geometry with concentric cylinders was used to represent the arteriole and its associated regions as shown in [Figure 2](#pone-0038912-g002){ref-type="fig"}. These regions include the luminal RBC (red blood cell) rich region (CR), RBC free region next to the vessel wall (CF), endothelium (E), interstitial space (IS) between the endothelium and smooth muscle cells, smooth muscle layer (SM), non-perfused parenchymal tissue (NPT) and perfused parenchymal tissue (PT) region. The CR region in the lumen of the arteriole was considered to have a homogenous solution of RBC's [@pone.0038912-Kavdia1]. The thickness of these different regions is shown in [Table 1](#pone-0038912-t001){ref-type="table"}. Three leukocytes were positioned on the luminal side of the endothelium for all the cases simulated and were named as L1, L2 and L3, respectively. Details about the leukocyte geometry and positioning of the leukocytes are described in the "Model Parameters" subsection.

![Geometrical description of the problem.\
**Panel A** shows the schematic of the arteriolar geometry. The geometry consists of concentric cylinders representing the different regions of the arteriole. The different regions fall under the category of either luminal or abluminal region. The luminal and abluminal regions are separated by the endothelial region (E). The luminal region consists of the RBC rich core (CR) and RBC free plasma region (CF). The abluminal region consists of the interstitial region (IS), smooth muscle region (SM), non-perfused (NPT) and capillary perfused (PT) parenchymal regions. L1, L2 and L3 represent the leukocytes interacting with the endothelium. P~in~ and P~out~ represent the inlet and outlet of the arteriolar/vessel segment, respectively. P~1~ and P~2~ represent the locations where the radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite were obtained and are located at distances of 230 and 345 µm, respectively from P~in~. **Panel B** shows the schematic of finite element mesh grid with relative accuracy set to 0.001.](pone.0038912.g002){#pone-0038912-g002}
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###### Model Parameters.

![](pone.0038912.t001){#pone-0038912-t001-1}

  Parameter                                 Value                          Units                                            Reference
  ------------------------ ---------------------------------------- -------------------- -------------------------------------------------------------------------------
  Systemic hematocrit                         45                             \%                         [@pone.0038912-Kavdia1], [@pone.0038912-Kavdia5]
  Capillary hematocrit                        30                             \%                        [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  C~RBC-Hb~                                  20.3                            mM                        [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  Arteriole radius                            25                             µm                                               Text
  CF region thickness                        4.5                             µm            [@pone.0038912-Kavdia2], [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  Endothelial thickness                      0.5                             µm                        [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  IS region thickness                        0.5                             µm                                      [@pone.0038912-Kavdia5]
  SM region thickness                         6                              µm                        [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  NPT region thickness                        30                             µm                        [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  O~2~ concentration                          27                             µM                                      [@pone.0038912-Kavdia5]
  CO~2~ concentration                        1.1                             mM                                      [@pone.0038912-Kavdia5]
  SOD concentration                         1, 10                            µM                                   [@pone.0038912-Buerk1], Text
  P~NO,E~                                5.3×10^−12^                 moles.cm^−2^.s^−1^   [@pone.0038912-Deonikar1], [@pone.0038912-Malinski1], [@pone.0038912-Vaughn1]
  P~O2~ ^•−^ ~,E~           2.7×10^−13^, 1.06×10^−12^, 5.3×10^−12^   moles.cm^−2^.s^−1^                           [@pone.0038912-Kavdia5], Text
  P~NO,PT~                                8.6×10^−7^                      M.s^−1^                                [@pone.0038912-Deonikar1], Text
  P~O2~ ^•−^ ~,PT~           4.3×10^−8^, 1.72×10^−7^, 8.6×10^−7^          M.s^−1^                                 [@pone.0038912-Kavdia5], Text
  P~NO,L1,L2,L3~                              10                          µM.s^−1^                                  [@pone.0038912-Nalwaya1]
  P~O2~ ^•−^ ~,L1,L2,L3~                 4.11×10^−5^                      M.s^−1^                                  [@pone.0038912-Tsukimori1]
  D~NO~                                   3.3×10^−5^                    cm^2^.s^−1^                                  [@pone.0038912-Kavdia5]
  D~O2~ ^•−^                              2.8×10^−5^                    cm^2^.s^−1^                     [@pone.0038912-Kavdia5], [@pone.0038912-Nalwaya2]
  D~Per~                                  2.6×10^−5^                    cm^2^.s^−1^                     [@pone.0038912-Kavdia5], [@pone.0038912-Nalwaya2]
  f (tissue)                                0.640                                                                    [@pone.0038912-Kavdia5]
  f (lumen)                                 0.817                                                                    [@pone.0038912-Kavdia5]
  v~zmax~                                    0.5                          cm.s^−1^                     [@pone.0038912-Kavdia3], [@pone.0038912-Deonikar1]
  k~NO-RBC~                               0.2×10^5^                     M^−1^.s^−1^                    [@pone.0038912-Kavdia1], [@pone.0038912-Deonikar2]
  k~cap~                                     1.77                          s^−1^                       [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  k~NO-O2~                                9.6×10^6^                     M^−2^.s^−1^                    [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  k~SM~                                    5×10^4^                      M^−1^.s^−1^                                  [@pone.0038912-Kavdia5]
  k~Per~                                  6.7×10^9^                     M^−1^.s^−1^                     [@pone.0038912-Kavdia5], [@pone.0038912-Potdar1]
  k~sod~                                  1.6×10^9^                     M^−1^.s^−1^                     [@pone.0038912-Kavdia5], [@pone.0038912-Potdar1]
  k~oxy~                                     4.5                           s^−1^                                     [@pone.0038912-Buerk1]
  k~CO2~                                  5.6×10^4^                     M^−1^.s^−1^                                  [@pone.0038912-Kavdia5]
  k~hb1~                                      30                           s^−1^                                     [@pone.0038912-Buerk1]
  k~NO-Per~                               9.1×10^4^                     M^−1^.s^−1^                                  [@pone.0038912-Kavdia5]

Model Assumptions {#s2b}
-----------------

The following were the assumption of the mathematical model:

1.  The convective transport of the species (NO, O~2~ ^•−^ and peroxynitrite) was assumed in the lumen (CR and CF regions) due to blood flow.

2.  The geometric parameters including thickness of the CR and CF regions were based on systemic hematocrit and vessel diameter [@pone.0038912-Kavdia2].

3.  The NO production rate from the endothelium was proportional to the shear stress exerted on the vessel wall due to blood flow [@pone.0038912-Kavdia3]. The shear stress on the vessel wall was calculated from apparent viscosity of blood (3 cPs), vessel diameter and physiological blood velocity (0.5 cm.s^−1^) using Newton's law of viscosity [@pone.0038912-Kavdia3]. The apparent blood viscosity was obtained from literature and is a function of systemic hematocrit [@pone.0038912-Coulter1].

4.  The basal case O~2~ ^•−^ production in the endothelium and capillary was assumed at 5% of their respective NO production. In basal case, leukocytes in inactivated state were modeled. We changed the NO production rate from the leukocytes and the O~2~ ^•−^ production rate in the endothelium, capillary and leukocytes depending on simulated-cases. These changes are described later in this section.

5.  The boundaries separating the different regions of the arteriole geometry and the outer surface of the perfused parenchymal tissue (PT) region were considered rigid.

6.  The simulations were performed at steady state.

7.  We assumed laminar flow in the lumen. The presence of leukocytes may affect the blood velocity profile. However, at physiological velocity, the convective transport of the modeled species can be neglected [@pone.0038912-Chen1], [@pone.0038912-Kavdia4].

8.  The arteriole geometry was considered to be axially symmetric and hence the computational domain involved only half of the complete vessel geometry starting from the central axis of the vessel to the outer surface of PT region. This assumption will affect the profile only when there is another leukocyte in the vicinity.

9.  We used three leukocytes for our simulations based on the experimental observations for leukocyte rolling flux and rolling velocity for TNF-α treated arterioles of ICAM-1 KO mice and wild type (WT) mice [@pone.0038912-Sumagin2]. Their reported values were 7 leukocytes/40 s and 32.2 µm.s^−1^ for ICAM-1 KO mice and 13 leukocytes/40 s and 53.5 µm.s^−1^ for WT mice. These two values results in 3.2 and 3.03 leukocytes per 500 µm vessel length. The calculations were performed based on the time taken by one leukocyte to traverse the length of the arteriole and the leukocyte rolling flux in that time period. It was also reported that in inflammatory conditions about 0.64 leukocytes/100 µm were adhered to arteriolar endothelium [@pone.0038912-Sumagin2], which translated to 3 adhered leukocytes for the vessel length used in this study (500 µm).

Governing Equations {#s2c}
-------------------

The transport of NO, O~2~ ^•−^ and peroxynitrite across different regions of the arteriole and within the leukocytes occurs due to both diffusion and convection. Additionally, these three species are also produced and consumed in different regions of the arteriole. Thus, the governing equation for their transport is a combination of the diffusion, convection, production and reaction kinetic terms. The transport of the three different chemical species (NO, O~2~ ^•−^ and peroxynitrite) were represented by three separate equations. The equations for mass transfer of NO, O~2~ ^•−^ and peroxynitrite across all the regions of the arteriole and the leukocyte were in the following form:Where the suffix i represents the chemical species (NO, O~2~ ^•−^ and peroxynitrite) and j the respective regions (i.e. CR, CF, E, IS, SM, NPT, PT, L1, L2 and L3). D~i~ (cm^2^.s^−1^) is the diffusivity of species i, C~i~ (nM) is the concentration of species i, R~i,j~ (M.s^−1^) represents the reaction rate of species i in the region j and P~i,j~ represents the production rate of species i in the region j (M.s^−1^). v~z~ (m.s^−1^) is the axial component of blood flow velocity and is a function of radial distance r [@pone.0038912-Deonikar1]. The blood flow was within the laminar flow range based on apparent Reynolds number calculations using a value of 3 cPs for apparent blood viscosity [@pone.0038912-Kavdia3]. Therefore, a parabolic velocity distribution of luminal blood flow was considered in this study. The velocity distribution was represented as a function of radial distance (r) in the following form [@pone.0038912-Deonikar1]:Where R (µm) is the radius of the arteriole (25 µm) and vzmax is the velocity of blood at the center of the arteriole (r = 0), which is also the maximum value of velocity.

Boundary Conditions {#s2d}
-------------------

The zero flux boundary condition was applied to the center of the arteriole (r = 0) and at the outer surface of the perfused parenchymal tissue (PT) region. The boundary conditions of continuity of NO, O~2~ ^•−^ and peroxynitrite were applied at all the interfaces with the exception of the interface between (a) the endothelium and the luminal cell free (CF) region and (b) the interstitial space (IS) and endothelium (E). At these interfaces, the boundary conditions involve the endothelium based NO and O~2~ ^•−^ production. Mathematically, the boundary condition at the interface between cell free (CF) and endothelium (E) region can be represented as follows:The boundary condition at the interface between the interstitial space (IS) and endothelium (E) can be mathematically represented as:In equation (3) and equation (4) the term Pi,E represents NO and O~2~ ^•−^ production in the endothelium. In the case of peroxynitrite, the continuous boundary condition was applied across all the interfaces as it was not produced directly in any region of the arteriole or within the leukocytes (PPer, j = 0).

Cases Simulated {#s2e}
---------------

Our understanding of the effects of the presence of leukocytes along the endothelium under different levels of endothelial oxidative stress and during activation of leukocytes is lacking. Five different cases were simulated to mimic the different levels of endothelial oxidative stress and leukocyte activation. The cases are as follows:

### Case 1 {#s2e1}

A normal physiologic condition − In these simulations, basal level of endothelial oxidative stress (O~2~ ^•−^ production in the endothelium and capillary was set at 5% of their respective NO production) and leukocytes in inactivated state were modeled.

### Case 2 {#s2e2}

Endothelial oxidative stress condition − In these simulations, the O~2~ ^•−^ production in the endothelium and capillary was set at 20% of their respective NO production and leukocytes were in inactivated state.

### Case 3 {#s2e3}

Combination of endothelial oxidative stress and activation of leukocytes − The O~2~ ^•−^ production in the endothelium and capillary was set at 20% of their respective NO production and leukocytes were in activated state producing NO and O~2~ ^•−^. The next two cases are based on this case. One is a therapeutic scenario and another is a severe oxidative stress condition that is the exacerbation of the Case 3 in the absence of any treatment.

### Case 4 {#s2e4}

Combination of endothelial oxidative stress, activated leukocytes and increased SOD concentration (a therapeutic scenario) − SOD concentration was increased by an order of magnitude from 1 µM to 10 µM globally across all regions of the arteriole geometry. Other conditions were the same as the Case 3.

### Case 5 {#s2e5}

Severe oxidative stress condition − The O~2~ ^•−^ production in the endothelium and capillary was set at 100% of their respective NO production and leukocytes were in activated state producing NO and O~2~ ^•−^.

Sources of NO and O~2~ ^•−^ Production {#s2f}
--------------------------------------

NO and O~2~ ^•−^ production occurs at the luminal and abluminal surfaces of the endothelium [@pone.0038912-Kavdia5]. The primary endothelium based NO source is the enzyme endothelial nitric oxide synthase (eNOS) while the primary endothelial O~2~ ^•−^ sources include NADPH oxidase and uncoupled eNOS [@pone.0038912-Kavdia5], [@pone.0038912-Forstermann1]. NO and O~2~ ^•−^ production also takes place in the perfused section of the parenchymal tissue region (PT) from capillary endothelium [@pone.0038912-Kavdia1], [@pone.0038912-Kavdia5] and in the leukocytes upon activation [@pone.0038912-He2], [@pone.0038912-Bellavite1], [@pone.0038912-Zhu1]. Kavdia and Popel [@pone.0038912-Kavdia3] proposed the following relationship between wall shear stress and endothelial NO release rate:P~NO_control,E~ is the basal rate of NO release by the endothelium at control wall shear stress (τ~wall_control~) of 24 dyne.cm^−2^ corresponding to the physiological blood velocity of 0.5 cm.s^−1^ and an apparent blood viscosity of 3 cPs in a 50 µm diameter arteriole [@pone.0038912-Kavdia3]. The control NO production rate in the endothelial region (P~NO_control,E~) used in this study was 5.3×10^−12^ moles.cm^−2^.s^−1^ based on the experimental data of Malinski et al. [@pone.0038912-Malinski1], [@pone.0038912-Vaughn1] in rabbit aorta. The basal rate of capillary based NO production in PT region is calculated from the endothelium based NO release rate by Kavdia and co-workers [@pone.0038912-Kavdia1], [@pone.0038912-Kavdia2] and was estimated to be (P~NO_control,PT~) 8.6×10^−7^ M.s^−1^.

The O~2~ ^•−^ production in these two regions (E and PT) was assumed to be a fraction of their respective NO production rates [@pone.0038912-Kavdia5] and varied as described in Cases Simulated subsection above. The leukocyte NO and O~2~ ^•−^ production rate were assumed to be 10 µM.s^−1^ and 41.1 µM.s^−1^, respectively. The leukocyte NO production rate was calculated from the inducible NOS (iNOS) enzyme based NO production rates from leukocytes of 3 pmoles.s^−1^/10^6^ cells reported by Nalwaya and Deen [@pone.0038912-Nalwaya1] The leukocyte O~2~ ^•−^ production rate was calculated from the O~2~ ^•−^ release rates of 12.33 pmoles.s^−1^/10^6^ cells reported by Tsukimori et al. [@pone.0038912-Tsukimori1]. The volume of 300 µm^3^ for a single leukocyte reported by Ting-Beall et al. [@pone.0038912-TingBeall1] was used to convert both these production rates into appropriate Molar units. The values of the NO and O~2~ ^•−^ production rates in the endothelium, perfused parenchymal region and leukocytes for the different cases simulated (Case 1 to Case 5) are shown in [Table 2](#pone-0038912-t002){ref-type="table"}.

10.1371/journal.pone.0038912.t002

###### Endothelial, capillary and leukocyte based NO and O~2~ ^•−^ production rates and SOD concentration for the different cases simulated.

![](pone.0038912.t002){#pone-0038912-t002-2}

  Case Number    P~i,E~ (pmoles.cm^−2^.s^−1^)   P~i,PT~ (µM.s^−1^)   C~SOD~ (µM)   P~i,L~ [1](#nt101){ref-type="table-fn"} (µM.s^−1^)              
  ------------- ------------------------------ -------------------- ------------- ---------------------------------------------------- ---- ------ ------
  Case 1                     5.3                       0.27             0.86                             0.043                          1     0      0
  Case 2                     5.3                       1.06             0.86                             0.172                          1     0      0
  Case 3                     5.3                       1.06             0.86                             0.172                          1    10.0   41.1
  Case 4                     5.3                       1.06             0.86                             0.172                          10   10.0   41.1
  Case 5                     5.3                       5.3              0.86                              0.86                          1    10.0   41.1

**P~i,L~** refers to the production rate of NO and O~2~ ^•−^ from the leukocytes L1, L2 and L3.

Chemical Reactions {#s2g}
------------------

NO, O~2~ ^•−^ and peroxynitrite undergo chemical reactions at all or specific regions within the arteriole geometry. The specifics of these reactions are shown in [Table 3](#pone-0038912-t003){ref-type="table"}. The rate constants pertaining to the different chemical reactions were either directly procured from literature or calculated (such as k~cap~). Amongst the reactions shown in [Table 3](#pone-0038912-t003){ref-type="table"}, the reaction involving NO and hemoglobin (Hb) in the CR and PT regions involve the two reactants (NO and Hb) and the RBC. The rate of consumption of NO by Hb in the CR region is represented as the product of NO reaction rate constant with RBC Hb (k~NO-RBC~), concentration of Hb in a single RBC (C~RBC-Hb~), systemic hematocrit and NO concentration. The values of these parameters and their sources are shown in [Table 1](#pone-0038912-t001){ref-type="table"}. In the PT region, the rate of reaction between NO and RBC is represented as the product of effective rate constant of reaction between NO and Hb in blood flowing in capillaries perfusing in the PT region (k~cap~) and the concentration of NO. k~cap~ is obtained by multiplying the NO reaction rate constant with RBC Hb (k~NO-RBC~), concentration of Hb in RBC (C~RBC-Hb~), capillary hematocrit and fractional capillary volume. The value of fractional capillary volume used was 0.0146 based on experimental data reported for hamster retractor muscle [@pone.0038912-Kavdia2], [@pone.0038912-Ellsworth1]. The other parameters used in calculation of k~cap~ are shown in [Table 1](#pone-0038912-t001){ref-type="table"}. Details regarding the calculation of k~cap~ can be found in articles by Kavdia and co-workers [@pone.0038912-Kavdia2], [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5].

10.1371/journal.pone.0038912.t003

###### Description of reactions and their kinetic expressions used in the model.

![](pone.0038912.t003){#pone-0038912-t003-3}

  Rxn \#             Reaction                Regions       Mathematical Expression                          Ref.
  -------- ---------------------------- ----------------- ------------------------- ----------------------------------------------------
  Rxn 1             NO and Hb                  CR                                    [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  Rxn 2             NO and Hb                  PT                                    [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  Rxn 3            NO and O~2~           CF, E, IS & NPT                                          [@pone.0038912-Kavdia5]
  Rxn 4             NO and sGC                 SM                                    [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]
  Rxn 5          NO and O~2~ ^•−^              All                                    [@pone.0038912-Kavdia5], [@pone.0038912-Buerk1]
  Rxn 6         O~2~ ^•−^ and SOD              All                                    [@pone.0038912-Kavdia5], [@pone.0038912-Buerk1]
  Rxn 7     Peroxynitrite Dissociation         All                                    [@pone.0038912-Kavdia5], [@pone.0038912-Buerk1]
  Rxn 8       Peroxynitrite & CO~2~            All                                                [@pone.0038912-Kavdia5]
  Rxn 9         Peroxynitrite & Hb           CR & PT                                               [@pone.0038912-Buerk1]
  Rxn 10        Peroxynitrite & NO             All                                    [@pone.0038912-Kavdia5], [@pone.0038912-Buerk1]

Model Parameters {#s2h}
----------------

The model parameters are reported in [Table 1](#pone-0038912-t001){ref-type="table"}. The dimensions of the elliptical leukocyte (semi-major and semi-minor axis) were assumed to be 4.9 and 3.5 µm, respectively. The leukocyte dimensions were based on the observations of deformation index of 1.36 by Damiano et al. [@pone.0038912-Damiano1] and a spherical diameter of leukocytes in resting state of 8.3 µm by Ting-Beall et al. [@pone.0038912-TingBeall1]. Damiano et al. [@pone.0038912-Damiano1] observed that adhesion molecule expression and shear stress due to blood flow contribute to change in leukocyte morphology from circular to elliptical and expressed this change in terms of a deformation index. The centers of these three leukocytes were located at distances of 38, 230.8 and 461.5 µm, respectively from the vessel inlet (P~in~) and at a radial distance of 3.5 µm from the luminal surface of the endothelium as shown in [Figure 2A](#pone-0038912-g002){ref-type="fig"}. The justification for other geometrical parameters is presented in earlier studies [@pone.0038912-Kavdia2], [@pone.0038912-Deonikar1], [@pone.0038912-Kavdia5]. For all the regions of the arteriole and within the leukocytes, the diffusivity of NO, O~2~ ^•−^ and peroxynitrite were 3.3×10^−5^, 2.8×10^−5^ and 2.6×10^−5^ cm^2^.s^−1^, respectively [@pone.0038912-Kavdia5], [@pone.0038912-Nalwaya2].

Numerical Solution {#s2i}
------------------

On the basis of Equation 1, a system of partial differential equations were generated for representing the transport and reactions involving NO, O~2~ ^•−^ and peroxynitrite. These equations with the appropriate boundary conditions were solved numerically using the finite element software package FlexPDE 5.0 (PDE solutions Inc., Antioch, CA, USA). This software uses adaptive meshing that generates finer elements in regions with steep concentration gradient and coarse meshing elsewhere within the domain as shown in [Figure 2B](#pone-0038912-g002){ref-type="fig"}. This optimizes the computational resources required for the simulations. For all the simulations used in this study, we used a relative accuracy of 0.001.

Results {#s3}
=======

The model used in this study predicts the steady state NO, O~2~ ^•−^ and peroxynitrite concentration distribution and radial profiles under normal and oxidative stress conditions in the presence of three leukocytes located along the luminal surface of the endothelium. The steady state radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite were obtained at two distinct locations along the axial direction of the arteriole as shown in [Figure 2A and B](#pone-0038912-g002){ref-type="fig"}. The first location passes through one of the leukocyte (location P~1~ in [Figure 2A and B](#pone-0038912-g002){ref-type="fig"}) present along the endothelium (L2). The second location passes through the midpoint between the centers of two leukocytes present along the endothelium (location P~2~ in [Figure 2A and B](#pone-0038912-g002){ref-type="fig"} between leukocytes L2 and L3). The first location was at a distance of 230 µm and the second at a distance of 345 µm. The NO concentration increased radially along the arteriole starting at the vessel center. The O~2~ ^•−^ and peroxynitrite concentration increased radially starting at the vessel center to a maximum at the endothelium (in some cases near the endothelium as stated) and reduced thereafter. The maximum endothelial NO, O~2~ ^•−^ and peroxynitrite concentrations at locations P~1~ and P~2~ for all the cases (Case 1−5) are shown in [Table 4](#pone-0038912-t004){ref-type="table"}. The NO, O~2~ ^•−^ and peroxynitrite concentration range in the different regions of the arteriole is shown in [Table 5](#pone-0038912-t005){ref-type="table"}.

10.1371/journal.pone.0038912.t004

###### Maximum endothelial concentrations of NO, O~2~ ^•−^ and peroxynitrite at location P~1~ [2](#nt102){ref-type="table-fn"} and location P~2~ [3](#nt103){ref-type="table-fn"}. C~Per~ refers to the peroxynitrite concentration.
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  Case Number    C~NO~ (nM)   C~O2~ ^•-^ (pM)   C~Per~ (nM)              
  ------------- ------------ ----------------- ------------- ------ ---- ----
  Case 1            262             250             431       426    2    2
  Case 2            240             229            1761       1741   6    6
  Case 3            226             229            5801       1741   41   6
  Case 4            285             251            1064       704    8    1
  Case 5            153             150            13447      9591   51   24

The location P~1~ refers to a straight line passing through the leukocyte L2 at a distance of 230 µm from the vessel inlet P~in~ as seen in [Figure 2](#pone-0038912-g002){ref-type="fig"}.

The location P~2~ refers to a straight line passing the centers of leukocytes L2 and L3 at a distance of 345 µm from the vessel inlet P~in~ as seen in [Figure 2](#pone-0038912-g002){ref-type="fig"}.

10.1371/journal.pone.0038912.t005

###### Concentration range of NO, O~2~ ^•−^ and peroxynitrite at different regions of the arteriole geometry.
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  Case Number    Regions   C~NO~ (nM)   C~Per~ (nM)   C~O2~ ^•−^ (pM)
  ------------- --------- ------------ ------------- -----------------
  **Case 1**     **CR**      0--140        0--1            0--7
                 **CF**      3--251       0.1--2          3--310
                  **E**      6--262        1--2          251--500
                 **IS**     69--264        1--2          247--500
                 **SM**     134--292      0.4--2         0.4--290
                 **NPT**    210--389      0.1--1           0--6
                 **PT**     375--469      0.4--1           7--10
  **Case 2**     **CR**      0--130        0--4            0--28
                 **CF**     0.2--230      0.4--6         14--1270
                  **E**      2--241        1--6         1040--2040
                 **IS**     65--242        1--6         1020--2030
                 **SM**     86--266        1--6           2--1240
                 **NPT**    192--353       1--3            0--26
                 **PT**     340--423       1--3           30--45
  **Case 3**     **CR**      0--119        0--33          0--7470
                 **CF**      3--219        0--44         16--6430
                  **E**      4--229        1--44        1090--6830
                 **IS**     64--232        1--41        1044--5063
                 **SM**     88--260        2--37          2--2800
                 **NPT**    191--351       1--12           0--26
                 **PT**     340--423       1--3           29--45
  **Case 4**     **CR**      0--162        0--8           0--990
                 **CF**      2--274        0--9           0--1100
                  **E**     0.4--286      0.1--9         220--1100
                 **IS**     61--287       0.2--8         210--1000
                 **SM**     95--305       0.3--7          0--250
                 **NPT**    209--393      0.1--2           0--5
                 **PT**     375--469      0.4--1           7--10
  **Case 5**     **CR**      0--80         0--43          0--8200
                 **CF**     0.2--145      0.2--53        20--12600
                  **E**      0--152        0--53        6200--13600
                 **IS**     45--152        4--51        6100--13600
                 **SM**     61--164        6--48         20--8000
                 **NPT**    121--201       2--18          0--170
                 **PT**     206--241       6--10         220--290

Concentration Distribution and Profiles of NO, O~2~ ^•−^ and Peroxynitrite Under Normal Physiological Conditions (Case 1) {#s3a}
-------------------------------------------------------------------------------------------------------------------------

Under normal physiological conditions, a small number of leukocytes may still roll along the endothelium primarily acting as surveillance against antigens or pathogenic foreign bodies [@pone.0038912-Kubes2]. Additionally, a small amount of O~2~ ^•−^ is released from endothelial cells under normal physiologic conditions [@pone.0038912-Kavdia5], [@pone.0038912-Zou1]. In this case (Case 1), leukocytes were considered to be inactivated as they are neither primed nor activated under normal physiologic conditions [@pone.0038912-He2], [@pone.0038912-Bellavite1], [@pone.0038912-Galkina1], [@pone.0038912-Hubbard1].

The NO, O~2~ ^•−^ and peroxynitrite concentrations are shown in [Figure 3A, C and E](#pone-0038912-g003){ref-type="fig"}, respectively for the entire vessel and in [Figure 3B, D and F](#pone-0038912-g003){ref-type="fig"}, respectively for a segment of the vessel between 200 and 300 µm encompassing the luminal, endothelial (E), smooth muscle (SM) and non-perfused parenchymal tissue (NPT) region. The concentration range of NO, O~2~ ^•−^ and peroxynitrite within the leukocytes were 88−248 nM, 0.2−200 pM, and 1−2 nM, respectively. The concentration range of NO, O~2~ ^•−^ and peroxynitrite at other regions of the arteriole are shown in [Table 5](#pone-0038912-t005){ref-type="table"}. The radial concentration profiles for NO, O~2~ ^•−^ and peroxynitrite at location P~1~ and P~2~ are shown in [Figure 4](#pone-0038912-g004){ref-type="fig"} A and B, respectively and their maximum values at the endothelium are shown in [Table 4](#pone-0038912-t004){ref-type="table"}.

![Concentration distribution under normal physiological conditions (Case 1).\
**Panel A, C and E** shows the NO, O~2~ ^•−^ and peroxynitrite (referred as C~Per~) concentration distribution, respectively across the entire arteriolar geometry. **Panel B,** **D** and **F** shows the NO, O~2~ ^•−^ and peroxynitrite concentration distribution, respectively across a segment of the arteriolar geometry between 200 and 300 µm encompassing the luminal, E, SM and NPT regions. The endothelial and capillary based O~2~ ^•−^ production rates in this case were 5% of their respective NO production rates and the leukocytes were considered inactive.](pone.0038912.g003){#pone-0038912-g003}

![Radial concentration profiles at locations P~1~ and P~2~ for the Case 1.\
**Panel A** and **B** shows the radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite at the location P~1~ and P~2~, respectively.](pone.0038912.g004){#pone-0038912-g004}

Concentration Distribution and Profiles of NO, O~2~ ^•−^ and Peroxynitrite Under The Endothelial Oxidative Stress Conditions (Case 2) {#s3b}
-------------------------------------------------------------------------------------------------------------------------------------

Under the endothelial oxidative stress condition (Case 2), the NO, O~2~ ^•−^ and peroxynitrite concentrations are shown in [Figure 5A, C and E](#pone-0038912-g005){ref-type="fig"}, respectively for the entire vessel and in [Figure 5B, D and F](#pone-0038912-g005){ref-type="fig"}, respectively for a segment of the vessel between 200 and 300 µm. Compared to the Case 1, the maximum concentration of NO decreased at all regions of the blood vessel and in the leukocytes. The concentration range of NO, O~2~ ^•−^ and peroxynitrite within the leukocytes were 81−231 nM, 1−1022 pM, and 2−6 nM, respectively. In comparison to the Case 1, the maximum NO concentration changed by 0.9 fold, whereas the maximum O~2~ ^•−^ and peroxynitrite concentrations increased by 5 and 4 fold, respectively. In the CR, CF, E and SM regions, the maximum NO concentration changed by 0.9 fold while the maximum O~2~ ^•−^ and peroxynitrite concentration increased by 4 fold, respectively.

![Concentration distribution under conditions of endothelial oxidative stress (Case 2).\
The NO, O~2~ ^•−^ and peroxynitrite concentration distribution are shown for the entire arteriolar geometry in **Panels A, C, and E**, respectively and across the 200--300 µm region in **Panels B, D and F**, respectively. The endothelial and capillary based O~2~ ^•−^ production rates in this case were 20% of their respective NO production rates and the leukocytes were considered inactive.](pone.0038912.g005){#pone-0038912-g005}

The radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite at location P~1~ and P~2~ are shown in [Figure 6](#pone-0038912-g006){ref-type="fig"} A and B, respectively. In comparison to the Case 1, the maximum endothelial NO concentration changed by 0.9 fold whereas the maximum endothelial O~2~ ^•−^ and peroxynitrite concentration increased by 4 fold, at location P~1~ and P~2~, respectively (see [Table 4](#pone-0038912-t004){ref-type="table"}).

![Radial concentration profiles at locations P~1~ and P~2~ for the Case 2.\
**Panel A** and **B** shows the radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite at the location P~1~ and P~2~, respectively.](pone.0038912.g006){#pone-0038912-g006}

The Combined Endothelial Oxidative Stress Conditions and the Activation of Leukocytes (Case 3): Significant Increase in Peroxynitrite Concentration Over a Length of 100 µm in Vicinity of a Leukocyte {#s3c}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

For the combination of the endothelial oxidative stress condition with the activation of leukocytes (Case 3), the NO, O~2~ ^•−^ and peroxynitrite concentration distribution are shown in [Figure 7](#pone-0038912-g007){ref-type="fig"}. Compared to the Case 2, the maximum NO concentration decreased at all regions of the blood vessel excluding PT region (remained unchanged in PT region) and the leukocytes. The concentration range of NO, O~2~ ^•−^ and peroxynitrite within the leukocytes were 78−216 nM, 7000−14000 pM and 23−53 nM, respectively. In comparison to the Case 2, the maximum NO concentration changed by 0.9 fold, whereas the maximum O~2~ ^•−^ and peroxynitrite concentrations increased by 14 and 8 fold, respectively. In comparison to the Case 2, the maximum NO concentration changed by 0.9 fold, the maximum O~2~ ^•−^ concentration increased by 267, 5, 3 and 2 fold, and the maximum peroxynitrite concentration increased by 9, 7, 7 and 6 fold in the CR, CF, E and SM regions, respectively.

![Concentration distribution under combination of endothelial oxidative stress and activation of leukocytes (Case 3).\
The NO, O~2~ ^•−^ and peroxynitrite concentration distribution are shown for the entire arteriolar geometry in **Panels A, C, and E,** respectively and across the 200--300 µm region in **Panels B, D and F,** respectively. The O~2~ ^•−^ production in the endothelium and capillary in this case were 20% of their respective NO production and the leukocytes were in activated state producing NO and O~2~ ^•−^.](pone.0038912.g007){#pone-0038912-g007}

At the CF, E and SM regions, the activation of leukocytes with the endothelial oxidative stress conditions results in greater fold increase in peroxynitrite concentration as compared to increase in O~2~ ^•−^ concentration. This is due to the iNOS related NO production from the activated leukocytes that reacts with O~2~ ^•−^ to form peroxynitrite. It also shows the ability of peroxynitrite to diffuse greater distances compared to O~2~ ^•−^ [@pone.0038912-Kavdia5]. In the CR region, the increase in O~2~ ^•−^ concentration is greater than peroxynitrite due to rapid scavenging of both NO and peroxynitrite by hemoglobin [@pone.0038912-Deonikar2], [@pone.0038912-Buerk1].

At the location P~1~ and P~2~, the radial concentration profiles for NO, O~2~ ^•−^ and peroxynitrite are shown in [Figure 8](#pone-0038912-g008){ref-type="fig"} for the Case 3. The location for the maxima for O~2~ ^•−^ and peroxynitrite at location P~1~ shifted from the endothelium (as observed in the previous cases (Case 1 and 2)) to the lumen at distances of 20.5 and 22.3 µm, respectively from the center of the vessel. The maximum O~2~ ^•−^ and peroxynitrite concentrations were 13300 pM and 51 nM, respectively. In comparison to the Case 2, the maximum endothelial NO concentration changed by 0.9 fold and the maximum O~2~ ^•−^ and peroxynitrite concentration increased by 3 and 6 fold, respectively at the location P~1~ ([Table 4](#pone-0038912-t004){ref-type="table"}). However at the location P~2~, the NO, O~2~ ^•−^ and peroxynitrite concentrations remained unchanged. Furthermore, the peroxynitrite increased in the vicinity of the activated leukocytes when compared in contour profiles of the Case 2 ([Figure 5F](#pone-0038912-g005){ref-type="fig"}) with the Case 3 ([Figure 7F](#pone-0038912-g007){ref-type="fig"}). A region of 100 µm in length can experience a significant increase in peroxynitrite concentration upon activation of a single leukocyte.

![Radial concentration profiles at locations P~1~ and P~2~ for the Case 3.\
**Panel A** **and B** shows the radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite at the location P~1~ and P~2~, respectively.](pone.0038912.g008){#pone-0038912-g008}

SOD Effectively Reduces Oxidative Stress Associated with the Endothelial Region and the Activation of Leukocytes (Case 4) {#s3d}
-------------------------------------------------------------------------------------------------------------------------

Experimental studies have demonstrated that the O~2~ ^•−^ scavenger superoxide dismutase (SOD) can inhibit leukocyte adhesion, reduce adhesion molecule expression and attenuate increase in vascular permeability [@pone.0038912-Kubes1], [@pone.0038912-Zhu1]. It is thus important to understand the effect of increased SOD on the concentration profiles from the Case 3. For the Case 4, we increased the SOD concentration from 1 to 10 µM. [Figures 9](#pone-0038912-g009){ref-type="fig"} and [10](#pone-0038912-g010){ref-type="fig"} shows the resulting concentration distributions and radial profiles, respectively. In comparison to the Case 3, the maximum O~2~ ^•−^ and peroxynitrite concentration reduced across all the regions of the blood vessel and in the leukocytes.

![Concentration distribution under endothelial oxidative stress, activated leukocytes and increased SOD concentration (Case 4).\
The NO, O~2~ ^•−^ and peroxynitrite concentration distribution are shown for the entire arteriolar geometry in **Panels A, C, and E,** respectively and across the 200--300 µm region in **Panels B, D and F,** respectively. The O~2~ ^•−^ production in the endothelium and capillary in this case were 20% of their respective NO production and the leukocytes were in activated state producing NO and O~2~ ^•−^. The SOD concentration across all the regions of the arteriole and within the leukocytes was set at 10 µM.](pone.0038912.g009){#pone-0038912-g009}

![Radial concentration profiles at locations P~1~ and P~2~ for the Case 4.\
**Panel A** and **B** shows the radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite at the location P~1~ and P~2~, respectively.](pone.0038912.g010){#pone-0038912-g010}

Within the leukocytes for the Case 4, the concentration range for NO, O~2~ ^•−^ and peroxynitrite were 106−277 nM, 1300−1940 pM and 5−11 nM, respectively. The maximum NO concentration increased 1.2 fold while the maximum O~2~ ^•−^ and peroxynitrite concentrations changed by 0.1 and 0.2 fold, respectively in comparison to the Case 3. In comparison to the Case 3, the maximum NO concentration increased by 1.4, 1.2, 1.2 and 1.1 fold in the CR, CF, E and SM regions, respectively (see [Table 5](#pone-0038912-t005){ref-type="table"}). The maximum O~2~ ^•−^ and peroxynitrite concentrations changed by 0.08−0.2 fold and by 0.2 fold, respectively in the CR, CF, E and SM regions. The peroxynitrite concentration significantly reduced in the vicinity of the leukocyte as compared to the Case 3.

Furthermore at the locations P~1~ and P~2,~ the maximum endothelial NO concentration increased by 1.2 fold, respectively in comparison to the Case 3. The O~2~ ^•−^ and peroxynitrite concentration reached their respective maximum values of 1938 pM and 10 nM at distances of 20.3 and 22.3 µm, respectively from the center of the vessel at the location P~1~. The maximum O~2~ ^•−^ concentrations changed by 0.2 and 0.4 fold and the maximum peroxynitrite concentrations changed by 0.2 fold at the locations P~1~ and P~2~, respectively.

An Onset of Severe Oxidative Stress Condition Affects All Regions of the Microvasculature (Case 5) {#s3e}
--------------------------------------------------------------------------------------------------

Endothelial oxidative stress in conjunction with activation of leukocytes causes a significant increase in peroxynitrite concentration in the endothelial region. An increased peroxynitrite concentration in the endothelial region can promote the oxidation of the eNOS co-factor BH~4~ to BH~2~ and causes eNOS uncoupling that results in reduction of eNOS based NO production, increased eNOS based O~2~ ^•−^ production and an increase in eNOS expression [@pone.0038912-Hink1], [@pone.0038912-Kar1]. However, it has also been reported that under inflammatory conditions there is an increase in iNOS expression and iNOS associated NO production from endothelial cells [@pone.0038912-Wilcox1], [@pone.0038912-Steiner1]. Thus, a prolonged exposure of the endothelium to high concentrations of peroxynitrite and leukocyte activation would eventually increase endothelial O~2~ ^•−^ production rate. In this scenario, the endothelial O~2~ ^•−^ production rate may equal or exceed the endothelial NO production progressing the Case 3 to the severe oxidative stress condition (Case 5).

[Figures 11](#pone-0038912-g011){ref-type="fig"} and [12](#pone-0038912-g012){ref-type="fig"} show the resulting concentration distributions and radial profiles, respectively. In comparison to the Case 3, the NO concentration reduced at all regions of the blood vessel and the leukocytes. Within the leukocytes for the Case 5, the concentration range for NO, O~2~ ^•−^ and peroxynitrite were 56−144 nM, 6500−14800 pM and 26−56 nM, respectively. The maximum NO concentration changed by 0.5 fold while the maximum O~2~ ^•−^ and peroxynitrite increased by 1.1 fold in comparison to the Case 3. In comparison to the Case 3, the maximum NO concentration changed by 0.6 fold and peroxynitrite concentrations increased by 1.3 fold across the CR, CF, E and SM regions. The O~2~ ^•−^ concentration increased by 1.1−3 fold in the CR, CF, E and SM regions, respectively (See [Table 5](#pone-0038912-t005){ref-type="table"}).

![Concentration distribution under severe oxidative stress conditions (Case 5).\
The NO, O~2~ ^•−^ and peroxynitrite concentration distribution are shown for the entire arteriolar geometry in **Panels A, C, and E,** respectively and across the 200--300 µm region in **Panels B, D and F,** respectively. The O~2~ ^•−^ production in the endothelium and capillary in this case were equal to their respective NO production and the leukocytes were in activated state producing NO and O~2~ ^•−^.](pone.0038912.g011){#pone-0038912-g011}

![Radial concentration profiles at locations P~1~ and P~2~ for the Case 5.\
**Panel A** **and** **B** shows the radial concentration profiles of NO, O~2~ ^•−^ and peroxynitrite at the location P~1~ and P~2~, respectively.](pone.0038912.g012){#pone-0038912-g012}

Furthermore at the locations P~1~ and P~2~, the maximum endothelial NO concentration changed by 0.6 fold in comparison to the Case 3. The O~2~ ^•−^ and peroxynitrite concentration reached their respective maximum values of 14672 pM and 55 nM at distances of 21.0 and 23.5 µm, respectively from the center of the vessel at the location P~1~. The maximum O~2~ ^•−^ concentrations increased by 2 and 6 fold and the maximum peroxynitrite concentrations increased by 1.2 and 4 fold at the locations P~1~ and P~2~, respectively. Thus, the severe oxidative stress condition (Case5) leads to a decrease in NO concentration across all regions of the arteriole and a significant increase in oxidative and nitrosative stress at regions of the arteriole previously unaffected under conditions presented in the Case 2 and 3, respectively (regions located between the centers of the leukocytes).

Discussion {#s4}
==========

There is a lack of sufficient measurement data of all these free radical levels in one study to validate the findings from our study. The modeling approach provides us improved understanding on the quantitative aspects of the complex interactions of NO and oxidative stress in the microcirculation. Overall, the results predicted by our models show similar trends to experimental observations as discussed below.

Limitations of Current Study {#s4a}
----------------------------

The model provides insight into the free radical levels changes during endothelial--leukocyte interactions from normal to oxidative stress state. The model predictions supported previous experimental observations about the independence between leukocyte adhesion and activation as described later. This modeling study has certain limitations. The results may vary depending on 1) the change in the blood vessel diameter due to vasoregulation, 2) the change in blood flow and velocity profile in the presence of endothelium interacting leukocytes, 3) the leukocyte migration and the presence of a nearby leukocyte. These limitations can be addressed by solving the multi-phase momentum transport equation involving blood and leukocytes [@pone.0038912-Lyczkowski1] simultaneously with the mass transport equations of the free radical species shown in equation (1). Additionally, moving boundary conditions need to be introduced at the interfaces separating adjacent regions of the vascular geometry. Such analysis will be extremely complex and will require enormous computational resources.

Transition from Normal Physiologic Conditions (Case 1) to Oxidative Stress Conditions (Case 2, 3 and 5) Leads to Significant Changes in Free Radical Profiles {#s4b}
-------------------------------------------------------------------------------------------------------------------------------------------------------------

Upon transition from normal physiology (Case 1) to endothelial oxidative stress conditions (Case 2), the results showed that the maximum O~2~ ^•−^ and peroxynitrite concentrations increased by 4 fold in the endothelial and smooth muscle region, respectively. Using DHE fluorescence, Gupte et al. [@pone.0038912-Gupte1] reported a 2 fold increase in O~2~ ^•−^ levels in the diabetic aortas as compared to aortas of healthy mice. Nagaoka et al. [@pone.0038912-Nagaoka1] showed that porcine arterioles incubated with a pro-inflammatory marker CRP caused a marked increase in O~2~ ^•−^ levels in the endothelium compared to untreated arterioles. They did not quantify the level of increase. El-Remessy and co-workers [@pone.0038912-ElRemessy1] reported a 1.4 fold increase in nitrotyrosine levels, which is an indirect indicator of peroxynitrite levels, for diabetic rat aortas.

The NO concentration changed by 0.9 fold in the endothelial and smooth muscle region in our simulations for the Case 2 in comparison to the Case 1. Akamine et al. [@pone.0038912-Akamine1] estimated the NO levels in mesenteric arterioles of normal and diabetic rats using DAF fluorescence. They reported approximately 0.8 fold change in NO levels of diabetic arterioles compared to normal arterioles. On the contrary, Jebelovszki et al. [@pone.0038912-Jebelovszki1] showed that the endothelial dependent vasodilation in arterioles of lean and obese rats were similar even though oxidative stress increased in vessels of obese rats. The NO concentration range for endothelial oxidative stress condition in the smooth muscle region predicted by this study was 86−266 nM. This is within NO levels required for half maximal activation of sGC (23−100 nM) [@pone.0038912-Kavdia2].

In addition, the results from this study predicted that in comparison to normal physiology (Case 1), the combination of endothelial oxidative stress and leukocyte activation (Case 3) changed the maximum NO concentration in the E and SM regions by 0.8 fold whereas the maximum O~2~ ^•−^ and peroxynitrite concentrations increased by 10−26 fold. The maximum O~2~ ^•−^ and peroxynitrite concentration in the cell-rich region increased by 1067 and 33 fold, respectively compared to normal physiology. Zhang et al. [@pone.0038912-Zhang1] compared the levels of O~2~ ^•−^ between normal and TNF-α treated porcine coronary arterioles using DHE fluorescence and observed augmented levels of O~2~ ^•−^ in the endothelial and smooth muscle region. Suematsu et al. [@pone.0038912-Suematsu1] showed that an infusion of rat venules with NOS inhibitor L-NAME and leukocyte activation agent fMLP (formyl-Met-Leu-Phe-OH) caused a 9 fold increase in endothelium ROS concentration. In a study involving rat microvasculature, it was observed that treatment with PAF antagonist reduced the ROS levels in the microvasculature by a factor of 0.6 [@pone.0038912-Casillan1].

Some of the above observations may lack the sufficient measurement data from the system that leads to disagreement in the modeling predictions and experimental observations. Possible explanation for the discrepancy in the extent of changes of free radical levels include higher O~2~ ^•−^ production and lower NO production in experimental conditions compared to the NO and O~2~ ^•−^ production rates used in our model. This could be due to activation of several sources of O~2~ ^•−^ production, inhibition or activation of NO production sources and differences in morphology of the endothelial cells. Additionally, oxidation of DHE by oxidizing agents other than O~2~ ^•−^ [@pone.0038912-Zhao1], [@pone.0038912-Wardman1], measurement of change in total ROS as opposed to just change in O~2~ ^•−^ and inhibition of DAF oxidation by antioxidants such as glutathione (GSH) and ascorbate [@pone.0038912-Wardman1] can also contribute to the disagreement between modeling and experimental results.

Consequences of Increased Oxidative Stress {#s4c}
------------------------------------------

Simulation of the severe oxidative stress condition (Case 5) using the computational model in this study predicted a significant decrease in the NO concentration and a significant increase in O~2~ ^•−^ and peroxynitrite concentration in the entire endothelial and smooth muscle region from the levels observed in the Case 3. This was more prominent between the leukocytes in the E and SM regions for severe oxidative stress, whereas the O~2~ ^•−^ and peroxynitrite concentration for Case 2 and 3 were similar (refer [Table 4](#pone-0038912-t004){ref-type="table"}). A comparison between severe oxidative stress condition (Case 5) and normal physiologic condition (Case 1) indicated that the maximum concentrations of NO changed by 0.6 fold, O~2~ ^•−^ increased by 27 and 28 fold, and peroxynitrite increased by 31 and 30 fold in the E and SM region, respectively. An increase in O~2~ ^•−^ and peroxynitrite concentration and a decrease in NO concentration in the vasculature has been implicated for vascular complications resulting from leukocyte-endothelial cell interactions [@pone.0038912-AlShabrawey1], [@pone.0038912-He2], [@pone.0038912-Csanyi1], [@pone.0038912-Szabo1].

The reduction in NO concentration in the SM region can severely impair vasodilation. Abu Nabah et al. [@pone.0038912-Nabah1] reported that arterioles of rats injected with eNOS inhibitor L-NAME showed a reduction in shear rate by a factor of 0.5, possibly due to reduced vasodilation. The increase in peroxynitrite concentration in the SM region can cause inhibition of smooth muscle cell growth and leads to their apoptosis. Huang et al. [@pone.0038912-Huang1] reported that a 5 fold increase in peroxynitrite concentration in smooth muscle cells causes their numbers to reduce by a factor of 0.16. Increase of O~2~ ^•−^ concentration in the endothelium could lead to deregulation of vascular permeability. Casillan et al. [@pone.0038912-Casillan1] observed a 10 fold increase in vascular permeability when the ROS concentration in the endothelium increased 1.6 fold. Therefore severe oxidative stress conditions may cause impairment of vasodilation, deregulation of vascular permeability, leukocyte transmigration to the SM region and apoptosis of smooth muscle cells. These could eventually lead to complications such as tissue edema and multiple organ failure [@pone.0038912-Sumagin1], [@pone.0038912-Galkina1].

Possible Effect on Leukocytes Because of the Transition from Normal Physiological Condition to the Endothelial Oxidative Stress Condition {#s4d}
-----------------------------------------------------------------------------------------------------------------------------------------

The maximum peroxynitrite concentration within the leukocytes and in the CR regions increased approximately by 4 fold upon transition from normal physiological condition (Case 1) to the endothelial oxidative stress condition (Case 2). Rohn et al. [@pone.0038912-Rohn1] reported that peroxynitrite is one of the priming agents for leukocytes. An increase in peroxynitrite concentration within leukocytes can prime them by upregulation of secondary stimulus receptors on their surface, depolarization of their mitochondrial membrane, increase in actin polymerization, enhancement of NADPH oxidase activity and increase in their intracellular \[Ca^2+^\] concentration [@pone.0038912-Rohn1], [@pone.0038912-Zimmerli1], [@pone.0038912-Adrie1]. Additionally, the maximum O~2~ ^•−^ concentration within the leukocytes and the CR regions increased by 5 and 4 fold, respectively upon transition from the Case 1 to 2. The increased concentration of O~2~ ^•−^ in the lumen through its dismutation product H~2~O~2~ can serve as secondary stimuli to the already primed circulating leukocytes within the lumen and activate them to produce NO and O~2~ ^•−^ without any direct interaction with the endothelium [@pone.0038912-He1], [@pone.0038912-He2]. Thus, priming and activation can also occur for leukocytes circulating in the lumen in oxidative stress conditions. This is in agreement with earlier studies that have shown that leukocyte adhesion to the endothelium and activation of leukocytes are two completely independent events [@pone.0038912-Zhu1], [@pone.0038912-Zeng1]. Additionally, the increase in peroxynitrite concentration within the leukocytes and the vasculature can cause tyrosine nitration, nitrosylation of various proteins, DNA strand breakage, increase in gene expression such as TNF-α, IL-6, IL-1β, ICAM-1 and P-selectin, and changes in signaling pathways such as MAP kinase, protein kinase C and NF-kβ, inactivation of anti-oxidant SOD, cell necrosis and cell apoptosis [@pone.0038912-Julius1], [@pone.0038912-Szabo1], [@pone.0038912-Pacher1].

Comparison of the simulation results in this study between normal physiological condition (Case 1) with that of the combination of endothelial oxidative stress and leukocyte activation (Case 3) shows that the maximum NO concentration in the leukocytes reduced by a factor of 0.9 while the maximum O~2~ ^•−^ and peroxynitrite concentration increased by 70 and 31 fold, respectively. Chemiluminescence analysis by Zhu et al. [@pone.0038912-Zhu1] on fMLP stimulated neutrophils indicated a 6 fold increase in their ROS concentration. Gagnon et al. [@pone.0038912-Gagnon1] used DHR 123 (dihydrorhodamine 123) based fluorescence analysis and reported a 2.4 fold increase in peroxynitrite concentration in LPS (lipopolysaccharide) treated granulocytes as compared to normal granulocytes. Information regarding measurement of changes in leukocyte NO concentration during activation of leukocytes is insufficient. However, it is reported that inhibition of leukocyte based NO production increases the expression of adhesion molecules on the leukocyte surface and promotes adhesion of leukocytes to the vessel wall [@pone.0038912-Liu1].

If the circulating leukocytes are monocytes then the increased O~2~ ^•−^ and peroxynitrite concentration within the monocytes may cause them to transform to macrophages [@pone.0038912-Lu1], [@pone.0038912-Fuhrman1]. Macrophages can transmigrate into the SM region causing proliferation of smooth muscle cells, ROS production from SM region, tissue injury and eventual vascular remodeling [@pone.0038912-Csanyi1], [@pone.0038912-Galkina1]. The excess peroxynitrite within the leukocytes can contribute to tissue injury by protein tyrosine nitration [@pone.0038912-Beckman1]. However, certain studies have argued against the role of peroxynitrite in tyrosine nitration of proteins and have attributed it to nitrite formed from oxidation of NO [@pone.0038912-Pfeiffer1], [@pone.0038912-Pfeiffer2]. Our study suggests the role of peroxynitrite in tyrosine nitration as it takes into account both the oxidation reaction of NO and the reaction between NO and O~2~ ^•−^ to form peroxynitrite.

Importance of SOD in Reduction of O~2~ ^•−^ and Peroxynitrite Concentrations During Endothelial Oxidative Stress Coupled with Leukocyte Activation {#s4e}
--------------------------------------------------------------------------------------------------------------------------------------------------

Several studies have shown SOD to be an effective therapeutic agent for treatment of leukocyte-endothelial cell interaction based vascular complications [@pone.0038912-Segui1], [@pone.0038912-Feng1], [@pone.0038912-Yang1]. Additionally an increase in SOD expression and activity was reported during endothelial dysfunction [@pone.0038912-Yang1], [@pone.0038912-Ceriello1]. We wanted to test the effectiveness of SOD as a therapeutic through our model. We observed a significant decrease in the O~2~ ^•−^ and peroxynitrite levels and an increase in the NO levels in the different regions of the vasculature and the leukocytes upon increasing the concentration of SOD from 1 to 10 µM across all the regions of the vessel and within the leukocytes under conditions of combined endothelial oxidative stress and leukocyte activation (transition from the Case 3 to the Case 4). Zhu et al. [@pone.0038912-Zhu1] compared the ROS production using chemiluminescence between untreated and SOD incubated neutrophils with both subjected to fMLP stimulation and observed that ROS levels in the SOD incubated neutrophils reduced by a factor of 0.3.

Zhu et al. [@pone.0038912-Zhu1] also reported that perfusion of venules with fMLP stimulated neutrophils caused an increase in intracellular Ca^2+^ concentration in endothelial cells, which was reduced by a factor of 0.7 upon perfusion with SOD. Bertuglia and Giusti [@pone.0038912-Bertuglia1] showed that microvessels subjected to ischemia reperfusion had 2 fold increase in ROS production and a decrease in RBC flow velocity by a factor of 0.9. However, ROS production and RBC flow velocity did not increase when these microvessels were treated with SOD. Murohara et al. [@pone.0038912-Murohara1] reported a significant reduction in vasoconstriction and leukocyte adhesion to the endothelium in arteries subjected to oxidative stress upon treatment of superoxide dismutase (SOD) and nitric oxide synthase (NOS) inhibitors. However, H~2~O~2~ and hydroxyl radial scavengers catalase and N-2-mercaptopropionyl-glycine (MPG), respectively had minimal effect on vasoconstriction and leukocyte adhesion.

Another qualitative study involving DHE-fluorescence imaging of TNF-α incubated arterioles showed a significant increase in O~2~ ^•−^ concentration in the E and SM region, which was considerably reduced upon addition of SOD mimetic Tempol [@pone.0038912-Zhang1]. In the lumen, the maximum O~2~ ^•−^ and peroxynitrite concentrations reduced by a factor of 0.1 and 0.2, respectively while the NO concentration increased by 1.2 fold. This could prevent the possible priming and activation of leukocytes circulating in the lumen and also prevent their recruitment towards the endothelium [@pone.0038912-He1], [@pone.0038912-He2], [@pone.0038912-Liu1]. Thus, the scavenging of O~2~ ^•−^ by SOD plays a key role in reducing peroxynitrite concentration, increasing NO bioavailability in SM region for vasodilation and prevention of leukocyte rolling, adhesion and activation [@pone.0038912-Kubes1], [@pone.0038912-Zhu1], [@pone.0038912-Frisbee1], [@pone.0038912-Kaul1]. SOD seems to be a promising candidate as potential therapeutic for treatment of vascular complications arising as a result of leukocyte-endothelial cell interactions.

**In conclusion,** the model developed in this study predicts the effects of the presence of leukocytes along the endothelium on NO, O~2~ ^•−^ and peroxynitrite concentration distribution in the microcirculation under several endothelial oxidative stress states. The results indicate that the onset of endothelial oxidative stress causes an increase in both O~2~ ^•−^ and peroxynitrite concentration within the leukocytes and the lumen, which can help prime (through peroxynitrite) and activate (secondary stimuli through O~2~ ^•−^) the leukocytes along the endothelium and those circulating in the lumen. The results thus provide an explanation to the previous experimental findings that leukocyte rolling/adhesion and activation are completely independent events and also explains the limited success of anti-adhesion therapies used to prevent vascular dysfunction [@pone.0038912-He2]. The results show that the oxidative and nitrosative stress during the leukocyte-endothelial cell interactions may possibly contribute to microvascular dysfunction and tissue injury.
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